Potential cost savings of erythropoietin administration in end-stage renal disease

Authors :: Hynes, Denise M.
Stroupe, Kevin T.
Greer, Joel W.
Reda, Domenic J.
Frankenfield, Diane L.
Kaufman, James S.
Henderson, William G.
Owen, William F., Jr.
Rocco, Michael V.
Wish, Jay B.
Kang, Jeffery
Feussner, John R.
Source :: American Journal of Medicine. Feb 15, 2002, Vol. 112 Issue 3, p169, 7 p.
Publication Year :: 2002

Subjects :: Erythropoietin -- Dosage and administration
Chronic kidney failure -- Drug therapy
Medical care, Cost of -- Analysis
Health
Health care industry

Tools